All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study

All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study

Luca Degli Esposti,1 Valentina Perrone,1 Chiara Veronesi,1 Stefano Buda,1 Roberta Rossini2 On behalf of the Local Health Unit group 1Clicon S.r.l. Health, Economics & Outcomes Research, Ravenna, Italy; 2Department of Cardiology, Papa Giovanni XXIII Hospital, Bergamo, Italy Objectives: The a...

Full description

Bibliographic Details
Main Authors: Degli Esposti L, Perrone V, Veronesi C, Buda S, Rossini R
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Vascular Health and Risk Management
Subjects:
dual platelet-aggregation inhibition
acute myocardial infarction
real world setting.
Online Access:https://www.dovepress.com/all-cause-mortality-cardiovascular-events-and-health-care-costs-after--peer-reviewed-article-VHRM

Internet

https://www.dovepress.com/all-cause-mortality-cardiovascular-events-and-health-care-costs-after--peer-reviewed-article-VHRM

Similar Items